M. Villalba, M. Rathore, N. Lopez-royuela, E. Krzywinska, J. Garaude et al., From tumor cell metabolism to tumor immune escape, The International Journal of Biochemistry & Cell Biology, vol.45, issue.1, 2013.
DOI : 10.1016/j.biocel.2012.04.024
URL : https://hal.archives-ouvertes.fr/inserm-00726717

C. Baier, A. Fino, C. Sanchez, L. Farnault, P. Rihet et al., Natural Killer Cells Modulation in Hematological Malignancies, Frontiers in Immunology, vol.4, p.3867693, 2013.
DOI : 10.3389/fimmu.2013.00459
URL : https://hal.archives-ouvertes.fr/hal-01455668

M. Villalba, N. Lopez-royuela, E. Krzywinska, M. Rathore, R. Hipskind et al., Chemical metabolic inhibitors for the treatment of blood-borne cancers. Anti-cancer agents in medicinal chemistry, pp.223-255, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01867009

E. Catalán, S. Charni, P. Jaime, J. Aguiló, J. Enríquez et al., MHC-I modulation due to metabolic changes regulates tumor sensitivity to CTL and NK cells, Oncoimmunology, vol.4, issue.1, p.25949869, 2015.

D. Mckenna, . Jr, D. Sumstad, N. Bostrom, D. Kadidlo et al., Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience, Transfusion, vol.26, issue.5, pp.520-528, 2007.
DOI : 10.1038/sj.bmt.1704810

J. Miller, Y. Soignier, A. Panoskaltsis-mortari, S. Mcnearney, G. Yun et al., Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer, Blood, vol.105, issue.8, pp.3051-3058, 2005.
DOI : 10.1182/blood-2004-07-2974

L. Ruggeri, A. Mancusi, E. Burchielli, F. Aversa, M. Martelli et al., Natural killer cell alloreactivity in allogeneic hematopoietic transplantation, Current Opinion in Oncology, vol.19, issue.2, pp.142-149, 2007.
DOI : 10.1097/CCO.0b013e3280148a1a

J. Rubnitz, H. Inaba, R. Ribeiro, S. Pounds, B. Rooney et al., NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia, Journal of Clinical Oncology, vol.28, issue.6, pp.955-964, 2010.
DOI : 10.1200/JCO.2009.24.4590

D. Sanchez-martinez, E. Krzywinska, M. Rathore, A. Saumet, A. Cornillon et al., All-trans retinoic acid (ATRA) induces miR-23a expression, decreases CTSC expression and granzyme B activity leading to impaired NK cell cytotoxicity, The International Journal of Biochemistry & Cell Biology, vol.49, pp.42-52, 2014.
DOI : 10.1016/j.biocel.2014.01.003
URL : https://hal.archives-ouvertes.fr/inserm-01867016

D. Sanchez-martinez, G. Azaceta, A. Muntasell, N. Aguilo, D. Nunez et al., lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells, OncoImmunology, vol.63, issue.3, p.4404803, 2015.
DOI : 10.1126/science.1068440
URL : https://hal.archives-ouvertes.fr/hal-01835574

N. Ramírez-comet, J. Aguiló, M. Rathoré, E. Catalán, J. Garaude et al., IFN-? signaling through PKC-? is essential for anti-tumor NK cell function, Oncoimmunology, vol.3, issue.8, pp.10-4161948705, 2014.

J. Aguilo, J. Garaude, J. Pardo, M. Villalba, and A. Anel, Protein Kinase C-?? Is Required for NK Cell Activation and In Vivo Control of Tumor Progression, The Journal of Immunology, vol.182, issue.4, pp.1972-81, 2009.
DOI : 10.4049/jimmunol.0801820
URL : https://hal.archives-ouvertes.fr/hal-02194087

Y. Bryceson, S. Chiang, S. Darmanin, C. Fauriat, H. Schlums et al., Molecular Mechanisms of Natural Killer Cell Activation, Journal of Innate Immunity, vol.185, issue.3, pp.216-242, 2011.
DOI : 10.4049/jimmunol.1000784

C. Domaica, M. Fuertes, I. Uriarte, M. Girart, J. Sardanons et al., Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development, PLoS One, vol.7, issue.12, p.3519873, 2012.

L. Moretta, Dissecting CD56dim human NK cells, Blood, vol.224, issue.19, pp.3689-91, 2010.
DOI : 10.1111/j.1600-065X.2008.00651.x

A. Freud, J. Yu, and M. Caligiuri, Human natural killer cell development in secondary lymphoid tissues Seminars in immunology, pp.132-139, 2014.

E. Krzywinska, N. Allende-vega, A. Cornillon, D. Vo, L. Cayrefourcq et al., Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers, EBioMedicine, vol.2, issue.10, pp.1364-76, 2015.
DOI : 10.1016/j.ebiom.2015.08.021
URL : https://hal.archives-ouvertes.fr/inserm-01867114

R. Kaplan, B. Morse, K. Huebner, C. Croce, R. Howk et al., Cloning of three human tyrosine phosphatases reveals a multigene family of receptor-linked protein-tyrosine-phosphatases expressed in brain., Proceedings of the National Academy of Sciences, vol.87, issue.18, pp.7000-7004, 1990.
DOI : 10.1073/pnas.87.18.7000

I. Rhee and A. Veillette, Protein tyrosine phosphatases in lymphocyte activation and autoimmunity, Nature Immunology, vol.76, issue.5, pp.439-486, 2012.
DOI : 10.1016/j.immuni.2010.08.001

K. Kishihara, J. Penninger, V. Wallace, T. Kundig, K. Kawai et al., Normal B lymphocyte development but impaired T cell maturation in CD45-Exon6 protein tyrosine phosphatase-deficient mice, Cell, vol.74, issue.1, pp.143-56, 1993.
DOI : 10.1016/0092-8674(93)90302-7

K. Byth, L. Conroy, S. Howlett, A. Smith, M. J. Alexander et al., CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation, Journal of Experimental Medicine, vol.183, issue.4, pp.1707-1725, 1996.
DOI : 10.1084/jem.183.4.1707

P. Mee, M. Turner, M. Basson, P. Costello, R. Zamoyska et al., Greatly reduced efficiency of both positive and negative selection of thymocytes in CD45 tyrosine phosphatase-deficient mice, European Journal of Immunology, vol.7, issue.9
DOI : 10.1128/MCB.16.9.4996

, Eur J Immunol, vol.29, issue.9, pp.2923-2956, 1999.

C. Kung, J. Pingel, M. Heikinheimo, T. Klemola, K. Varkila et al., Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease, Nature Medicine, vol.17, issue.3, pp.343-348, 2000.
DOI : 10.1089/dna.1998.17.779

E. Tchilian, D. Wallace, R. Wells, D. Flower, G. Morgan et al., A Deletion in the Gene Encoding the CD45 Antigen in a Patient with SCID, The Journal of Immunology, vol.166, issue.2, pp.1308-1321, 2001.
DOI : 10.4049/jimmunol.166.2.1308

T. Mustelin, T. Vang, and N. Bottini, Protein tyrosine phosphatases and the immune response, Nature Reviews Immunology, vol.278, issue.1, pp.43-57, 1530.
DOI : 10.1074/jbc.M307152200

N. Allende-vega, E. Krzywinska, S. Orecchioni, N. Lopez-royuela, F. Reggiani et al., The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism, Oncotarget, vol.6, issue.22, pp.19228-19273, 2015.
DOI : 10.18632/oncotarget.4653
URL : https://hal.archives-ouvertes.fr/inserm-01868552

M. Hermiston, J. Zikherman, J. Zhu, C. Cd45, and L. , CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells, Immunological Reviews, vol.31, issue.1, pp.288-311, 2009.
DOI : 10.4049/jimmunol.179.7.4704

V. Beziat, B. Descours, C. Parizot, P. Debre, and V. Vieillard, NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs, PLoS ONE, vol.4, issue.8, p.2917352, 2010.
DOI : 10.1371/journal.pone.0011966.s003

J. Clausen, B. Vergeiner, M. Enk, A. Petzer, G. Gastl et al., Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells, Immunobiology, vol.207, issue.2, pp.85-93, 2003.
DOI : 10.1078/0171-2985-00219

K. Juelke, M. Killig, M. Luetke-eversloh, E. Parente, J. Gruen et al., CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells, Blood, vol.4, issue.1, pp.1299-307, 2009.
DOI : 10.1038/nprot.2008.211
URL : http://www.bloodjournal.org/content/116/8/1299.full.pdf

S. Lopez-verges, J. Milush, S. Pandey, V. York, J. Arakawa-hoyt et al., CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset, Blood, vol.116, issue.19, pp.3865-74, 2010.
DOI : 10.1182/blood-2010-04-281675

K. Elpek, M. Rubinstein, A. Bellemare-pelletier, A. Goldrath, and S. Turley, Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15R?? complexes, Proceedings of the National Academy of Sciences, vol.17, issue.4, pp.21647-52, 2010.
DOI : 10.1016/j.cytogfr.2006.05.001
URL : http://www.pnas.org/content/107/50/21647.full.pdf

N. Vey, J. Bourhis, N. Boissel, D. Bordessoule, T. Prebet et al., A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission, Blood, vol.31, issue.9, pp.4317-4340, 2012.
DOI : 10.1016/j.it.2010.06.003

J. Wang and K. Pantopoulos, Regulation of cellular iron metabolism, Biochemical Journal, vol.18, issue.3, pp.365-81, 2011.
DOI : 10.1126/science.283.5402.676
URL : http://www.biochemj.org/content/ppbiochemj/434/3/365.full.pdf

B. Grzywacz, N. Kataria, and M. Verneris, CD56dimCD16+ NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases, Leukemia, vol.143, issue.2, pp.356-365, 2007.
DOI : 10.1006/cimm.1994.1268
URL : http://www.nature.com/leu/journal/v21/n2/pdf/2404499a.pdf

L. Lajoie, C. , N. Bolzec, A. Gouilleux-gruart, V. Sicard et al., ADAM17-Mediated Shedding of Fc??RIIIA on Human NK Cells: Identification of the Cleavage Site and Relationship with Activation, The Journal of Immunology, vol.192, issue.2, pp.741-51, 2014.
DOI : 10.4049/jimmunol.1301024

D. Hesslein, E. Palacios, J. Sun, J. Beilke, S. Watson et al., Differential requirements for CD45 in NK-cell function reveal distinct roles for Syk-family kinases, Blood, vol.158, issue.4, pp.3087-95, 2011.
DOI : 10.1128/MCB.18.7.4209
URL : http://www.bloodjournal.org/content/117/11/3087.full.pdf

L. Mason, J. Willette-brown, L. Taylor, and D. Mcvicar, Regulation of Ly49D/DAP12 Signal Transduction by Src-Family Kinases and CD45, The Journal of Immunology, vol.176, issue.11, pp.6615-6638, 2006.
DOI : 10.4049/jimmunol.176.11.6615
URL : http://www.jimmunol.org/content/jimmunol/176/11/6615.full.pdf

D. Hesslein, R. Takaki, M. Hermiston, A. Weiss, and L. Lanier, Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production, Proceedings of the National Academy of Sciences, vol.18, issue.1, pp.7012-7019, 2006.
DOI : 10.1016/S1074-7613(02)00505-8

N. Huntington, Y. Xu, S. Nutt, and D. Tarlinton, A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells, The Journal of Experimental Medicine, vol.163, issue.9, pp.1421-1454, 2005.
DOI : 10.1084/jem.187.5.807
URL : http://jem.rupress.org/content/jem/201/9/1421.full.pdf

X. Fu, Y. Liu, L. Li, Q. Li, D. Qiao et al., Human natural killer cells expressing the memory-associated marker CD45RO from tuberculous pleurisy respond more strongly and rapidly than CD45RO??? natural killer cells following stimulation with interleukin-12, Immunology, vol.30, issue.1, pp.41-50, 2011.
DOI : 10.1002/(SICI)1521-4141(200005)30:5<1364::AID-IMMU1364>3.0.CO;2-U
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2567.2011.03464.x/pdf